Gynica is a clinical-stage biotech company developing a non-hormonal, targeted drug for endometriosis. Our approach combines proprietary formulation with a localized, controlled-release delivery mechanism designed for optimal safety and efficacy. Unlike existing treatments, Gynica’s solution aims to reduce pain and inflammation without hormonal side effects, addressing a significant unmet need in women’s health.